Clincosm LogoSign in Get a demo

ovarian cancer

Showing NaN - NaN of 86
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in United States (PRO1184)

Recruiting
  • Ovarian Cancer
  • +8 more
  • Scottsdale, Arizona
  • +11 more
Jan 31, 2023

Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Tumors Trial in Worldwide (biological, drug, other)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Pembrolizumab
  • +4 more
  • Phoenix, Arizona
  • +178 more
Jan 25, 2023

NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

Recruiting
  • Non-small Cell Lung Cancer
  • +11 more
  • Birmingham, Alabama
  • +32 more
Jan 4, 2023

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
Has Results
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Ovarian Cancer Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

Recruiting
  • Low Grade Ovarian Serous Adenocarcinoma
  • Ovarian Cancer
  • avutometinib (VS-6766)
  • avutometinib (VS-6766) and Defactinib
  • Scottsdale, Arizona
  • +46 more
Dec 29, 2022

NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in Canada, United States (PF-06946860, Placebo for PF-06946860)

Completed
  • Non-small Cell Lung Cancer
  • +9 more
  • Little Rock, Arkansas
  • +32 more
Dec 12, 2022

Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High Trial in United States

Recruiting
  • Advanced or Metastatic Solid Tumors
  • +11 more
  • Tucson, Arizona
  • +11 more
Dec 2, 2022

Ovarian Cancer Trial in Worldwide (Alpelisib, Olaparib, Paclitaxel)

Recruiting
  • Ovarian Cancer
  • Phoenix, Arizona
  • +116 more
Nov 25, 2022

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Tumors Trial in Worldwide (Paclitaxel, Carboplatin, Atezolizumab)

Completed
  • Ovarian Cancer
  • +2 more
  • Phoenix, Arizona
  • +267 more
Nov 7, 2022

Ovarian Cancer, Breast Cancer, Solid Tumor Trial in Houston, Brisbane (CYH33)

Recruiting
  • Ovarian Cancer
  • +4 more
  • New Haven, Connecticut
  • +6 more
Oct 10, 2022

Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

Recruiting
  • Solid Tumor
  • +11 more
  • TRK-950
  • +14 more
  • Scottsdale, Arizona
  • +13 more
Oct 2, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Tumors Trial in Worldwide (Pembrolizumab, Placebo for pembrolizumab,

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Pembrolizumab
  • +7 more
  • Birmingham, Alabama
  • +226 more
Aug 22, 2022

Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • Duarte, California
  • +87 more
Aug 19, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Advanced Cancer, Ovarian Cancer, Lung Cancer Trial in United States (Dose escalation: COM902 monotherapy., Evaluation of

Recruiting
  • Advanced Cancer
  • +6 more
  • Dose escalation: COM902 monotherapy.
  • +3 more
  • Grand Rapids, Michigan
  • +5 more
Aug 8, 2022

NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • Tucson, Arizona
  • +26 more
Aug 1, 2022

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Mirvetuximab soravtansine
  • Anchorage, Alaska
  • +55 more
Jul 25, 2022

Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,

Recruiting
  • Any Advanced Solid Tumors
  • +6 more
  • Tampa, Florida
  • +7 more
Jul 13, 2022

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Worldwide (tisotumab vedotin)

Completed
  • Ovarian Cancer
  • +2 more
  • tisotumab vedotin
  • San Jose, California
  • +36 more
Jul 8, 2022

Advanced Cancer, Metastatic Cancer, Ovarian Cancer Trial in United Kingdom, United States (ART0380, Gemcitabine, Irinotecan)

Recruiting
  • Advanced Cancer
  • +4 more
  • Denver, Colorado
  • +10 more
Jul 6, 2022

Ovarian Cancer Trial in Worldwide (NovoTTF-100L(O), Paclitaxel)

Active, not recruiting
  • Ovarian Cancer
  • Phoenix, Arizona
  • +118 more
Apr 19, 2022

Acute Myeloid Leukemia, MDS, Glioblastoma Multiforme Trial in United States (DSP-7888 Dosing Emulsion)

Completed
  • Acute Myeloid Leukemia
  • +8 more
  • DSP-7888 Dosing Emulsion
  • Denver, Colorado
  • +7 more
Apr 4, 2022

Ovarian Cancer, Breast Cancer Trial in Dallas (Lynparza)

Active, not recruiting
  • Ovarian Cancer
  • Breast Cancer
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Mar 22, 2022

Ovarian Cancer, Hepatocellular Carcinoma, NSCLC Trial in Canada, United States (DPX-Survivac, Cyclophosphamide, Pembrolizumab)

Active, not recruiting
  • Ovarian Cancer
  • +4 more
  • DPX-Survivac
  • +2 more
  • Tucson, Arizona
  • +22 more
Mar 28, 2022